Showing results (1-10 of 78) with videos related to
Sort By:
Pageof 8
Virchows Archiv : an International Journal of Pathology|January 21, 2026
Low microsatellite instability revisited: a reviewBianca Grosser, Meike Kohlruss, Gisela KellerExpert Reviews in Molecular Medicine|September 15, 2005
Molecular medicine of gastric adenocarcinomasGisela Keller, Heinz Höfler, Karl-Friedrich BeckerAdvances in Experimental Medicine and Biology|December 14, 2006
Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tractHeinz Höfler, Rupert Langer, Katja Ott, et al.Recent Results in Cancer Research. Fortschritte Der Krebsforschung. Progres Dans Les Recherches Sur Le Cancer|July 5, 2007
Prediction of response to neoadjuvant chemotherapy in carcinomas of the upper gastrointestinal tractHeinz Höfler, Rupert Langer, Katja Ott, et al.Journal of Cancer Research and Clinical Oncology|March 16, 2006
Lack of prognostic impact of p53 gene mutation and p53 phosphorylation at serine 15 in multimodally treated adenocarcinomas of the gastroesophageal junctionFranziska Pühringer-Oppermann, Michael Stahl, Gisela Keller, et al.Human Mutation|February 13, 2004
Identification of four novel melanocortin 1 receptor (MC1R) gene variants in a Mediterranean populationMaria Concetta Fargnoli, Sergio Chimenti, Gisela Keller, et al.Modern Pathology : an Official Journal of the United States and Canadian Academy of Pathology, Inc|December 7, 2010
Genetic aberrations in primary esophageal melanomas: molecular analysis of c-KIT, PDGFR, KRAS, NRAS and BRAF in a series of 10 casesRupert Langer, Karen Becker, Marcus Feith, et al.Chirurgie (Heidelberg, Germany)|August 9, 2024
[Gender medicine in diseases of the upper gastrointestinal tract]Patrick S Plum, Stefan P Mönig, Ines Gockel, et al.Melanoma Research|March 29, 2006
Contribution of melanocortin-1 receptor gene variants to sporadic cutaneous melanoma risk in a population in central Italy: a case-control studyMaria Concetta Fargnoli, Emma Altobelli, Gisela Keller, et al.Journal of Clinical Pathology|October 7, 2010
Expression of class I histone deacetylases (HDAC1 and HDAC2) in oesophageal adenocarcinomas: an immunohistochemical studyRupert Langer, Kathrin Mutze, Karen Becker, et al.Pageof 8